Improved Assays and Predictive Tools for Drug Lead Optimization
Advanced Strategies to Study Plasma Protein Binding, Improve PK/PD, and Develop Better Enzyme Inhibitors
Diet, the Gut Microbiome, and Colorectal Cancer: Are They Linked?
Updates on Microbial Associations and Therapeutic Implications
Building the Ideal Bioprocessing Strategy
Searching for Innovative, Cost-Effective Product Options
New Tack for Neurodegenerative Disease Research
Armed with New Tools and Lower Cost Sequencing, Researchers Take an Omics Approach to Neuro Diseases
For full access to this article login to GEN Select now.
Simplifying Complex Biological Matrices
- Protein therapeutics is a fast-growing segment within the global pharmaceutical industry. Six thousand biologic drugs were in clinical trials in 2009 compared to 1,200 in 2005. By 2014, six of the top 10 drugs on the market will be biologics, according to a 2011 Thompson Reuters–Newport study of U.S. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.